コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e and patient type (with vs without systemic lupus erythematosus).
2 ciated disease in a murine model of systemic lupus erythematosus.
3 stic of autoimmune diseases such as systemic lupus erythematosus.
4 n CD4(+) T cells from patients with systemic lupus erythematosus.
5 ldhood and are also associated with systemic lupus erythematosus.
6 granulocytes from individuals with systemic lupus erythematosus.
7 n implicated in the pathogenesis of systemic lupus erythematosus.
8 is, inflammatory bowel disease, and systemic lupus erythematosus.
9 es syndrome and are associated with systemic lupus erythematosus.
10 s with autoimmune diseases, such as systemic lupus erythematosus.
11 B cell hyperactivity, hallmarks of systemic lupus erythematosus.
12 role of RAGE in the pathogenesis of systemic lupus erythematosus.
13 uch as rheumatoid arthritis (RA) or systemic lupus erythematosus.
14 ile idiopathic arthritis (SJIA) and systemic lupus erythematosus.
15 ytopenia, rheumatoid arthritis, and systemic lupus erythematosus.
16 limited autoimmunity in a model of systemic lupus erythematosus.
17 C1q and C1r/C1s deficiencies cause systemic lupus erythematosus.
18 reased morbidity in patients with systematic lupus erythematosus.
19 plication of the autoimmune disease systemic lupus erythematosus.
20 hogenesis of the autoimmune disease systemic lupus erythematosus.
21 genetic susceptibility regions for systemic lupus erythematosus.
22 LR signaling in the pathogenesis of systemic lupus erythematosus.
23 was recently approved for nonrenal systemic lupus erythematosus.
24 cause of morbidity and mortality in systemic lupus erythematosus.
25 erlaps with the autoimmune disorder systemic lupus erythematosus.
26 y-producing autoreactive B cells in systemic lupus erythematosus.
27 ing posttransplant vasculopathy and systemic lupus erythematosus.
28 athic arthritis and childhood-onset systemic lupus erythematosus.
29 le in the molecular pathogenesis of systemic lupus erythematosus.
30 dysfunction and is associated with systemic lupus erythematosus.
31 diabetes, rheumatoid arthritis, and systemic lupus erythematosus.
32 models of rheumatoid arthritis and systemic lupus erythematosus.
33 t of disease activity and damage in systemic lupus erythematosus.
34 ymorphisms that are associated with systemic lupus erythematosus.
35 utoantibody-driven diseases such as systemic lupus erythematosus.
36 sm for its increased production in cutaneous lupus erythematosus.
37 y be a viable therapeutic target in systemic lupus erythematosus.
38 sis, inflammatory bowel disease and systemic lupus erythematosus.
39 e use of BAFF-targeted therapies in systemic lupus erythematosus.
40 ound in AA, autoimmune uveitis, and systemic lupus erythematosus.
41 hy individuals and in patients with systemic lupus erythematosus.
42 classic mouse model of spontaneous systemic lupus erythematosus.
43 ablasts/PCs in patients with active systemic lupus erythematosus.
44 of intracellular innate sensors in systemic lupus erythematosus.
45 6.7%]), psoriasis (18 [20.9%]), and systemic lupus erythematosus (12 [14.0%]) were the most common au
46 and than the level in patients with systemic lupus erythematosus (1346+/-1011 pg per milliliter), ank
47 d inflammatory bowel disease, 2 had systemic lupus erythematosus, 2 had multiple sclerosis, 2 had aut
48 tibodies that are characteristic of systemic lupus erythematosus, a chronic autoimmune disease with m
50 heumatoid arthritis, multiple sclerosis, and lupus erythematosus, adjusting for age, gender, race, an
52 ed with autoimmune diseases such as systemic lupus erythematosus, Aicardi-Goutieres syndrome (AGS) an
53 examined B cells from patients with systemic lupus erythematosus, an autoimmune disorder with a stron
54 osus (DLE) is a chronic variant of cutaneous lupus erythematosus, an autoimmune inflammatory disorder
56 ydroxychloroquine used for treating systemic lupus erythematosus and a Syk inhibitor blocked NA-TLR l
57 human autoimmune diseases including systemic lupus erythematosus and Crohn's disease, and relevant au
58 delian disorders, most particularly systemic lupus erythematosus and dermatomyositis, are also charac
59 remarkable for an aunt who died of systemic lupus erythematosus and for a brother with arthritis.
62 ed with autoimmune diseases such as systemic lupus erythematosus and neuromyelitis optica, and can le
63 asma cells (PCs), are a hallmark of systemic lupus erythematosus and play a key role in disease patho
65 nhibitory pathways in two systemic (systemic lupus erythematosus and rheumatoid arthritis) and two or
68 appa may play a pathogenic role in cutaneous lupus erythematosus and serve as a target for treatment.
70 -regulated in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy, and preclin
72 y the alpha interferon signature of systemic lupus erythematosus and the interleukin-1 signature in s
76 ic anemia (AA), autoimmune uveitis, systemic lupus erythematosus, and sickle cell disease, respective
77 iguring and common manifestation in systemic lupus erythematosus, and the etiology of this predisposi
78 results with those in patients with systemic lupus erythematosus, ankylosing spondylitis, and hepatic
79 cardi-Goutieres syndrome and severe systemic lupus erythematosus are generally lethal disorders that
81 c diseases rheumatoid arthritis and systemic lupus erythematosus, as well as the spondyloarthropathie
84 versial role in the pathogenesis of systemic lupus erythematosus, but the underlying mechanisms remai
85 component C3 have been reported in systemic lupus erythematosus, but their molecular mechanism and f
86 B cells play an important role in systemic lupus erythematosus by acting not only as precursors of
87 icardi-Goutieres syndrome (AGS) and systemic lupus erythematosus, can arise when TREX1 function is co
88 ype 1 diabetes, multiple sclerosis, systemic lupus erythematosus, celiac disease, Crohn's disease, Ad
89 us erythematosus patient cells, and systemic lupus erythematosus cells with high IFN signature respon
90 lupus is a rare, autosomal dominant form of lupus erythematosus characterized by cold-induced inflam
92 will help exclude disorders such as systemic lupus erythematosus, common variable immunodeficiency, a
93 complex-mediated diseases, such as systemic lupus erythematosus, commonly affect the kidney and dete
94 usion values from all patients with systemic lupus erythematosus correlated positively with systemic
95 of the systemic autoimmune disease systemic lupus erythematosus correlating with disease activity.
98 ion of these diffusivities with the systemic lupus erythematosus disease activity index are in line w
99 ematosus correlated positively with systemic lupus erythematosus disease activity index score (P = 0.
103 t patients with prostate cancer and systemic lupus erythematosus exhibit reduced DNase I activity, an
104 D cells obtained from patients with systemic lupus erythematosus exhibited increased CD45 activity an
107 Investigations of patients with systemic lupus erythematosus have applied insights from studies o
108 mic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibrosis and d
109 s implicated in the pathogenesis of systemic lupus erythematosus in human patients and murine models
110 res syndrome and syndromic forms of systemic lupus erythematosus, including familial chilblain lupus
112 y of human rheumatoid arthritis and systemic lupus erythematosus, indicating that increased autophagy
122 ntral nervous system involvement in systemic lupus erythematosus is common and results in several neu
123 bate the symptoms of the autoimmune disorder lupus erythematosus is not known but may involve a role
124 Evaluation of discoid and subacute cutaneous lupus erythematosus lesions showed significant epidermal
126 cgammaRIIB-deficient mice develop a systemic lupus erythematosus-like disease at a markedly accelerat
128 scular/autoimmune disorders such as systemic lupus erythematosus; lymphoproliferative disorders such
130 serious adverse events (periorbital oedema, lupus erythematosus [occurring twice], erythema, and der
131 dverse events-periorbital oedema (one [4%]), lupus erythematosus (one [4%]), and dermohypodermitis (o
133 -driven autoimmune diseases such as systemic lupus erythematosus or psoriasis, but pDCs are also invo
135 TBK1 gene expression is elevated in systemic lupus erythematosus patient cells, and systemic lupus er
137 pression is increased in T cells of systemic lupus erythematosus patients and that this increased exp
142 ease activity was assessed with the Systemic Lupus Erythematosus Pregnancy Disease Activity Index and
144 ypical NKs purified from spleens of systemic lupus erythematosus-prone mice, and identified as NK1.1(
145 ated with type I diabetes mellitus, systemic lupus erythematosus, RA, and celiac disease, these resul
146 between SJS/TEN and pre-existing depression, lupus erythematosus, recent pneumonia, chronic kidney di
147 composite responder indices such as Systemic Lupus Erythematosus Responder Index (SRI) and BILAG-base
148 ses of an autoimmune disease called systemic lupus erythematosus reveals a new twist on an old story.
150 urrent and future impact of AMDs on systemic lupus erythematosus, rheumatoid arthritis, and devastati
151 o cause autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple
152 immune connective tissue disorders: systemic lupus erythematosus, rheumatoid arthritis, systemic scle
154 s, such as rheumatoid arthritis and systemic lupus erythematosus, show a polygenic inheritance patter
156 o determine their associations with systemic lupus erythematosus (SLE) and clinical manifestations of
157 e frequently found in patients with systemic lupus erythematosus (SLE) and correlate with the occurre
158 y-containing serum from humans with systemic lupus erythematosus (SLE) and from a mouse model of SLE
159 n C1q deficiency is associated with systemic lupus erythematosus (SLE) and increased susceptibility t
161 UBE2L3 is strongly associated with systemic lupus erythematosus (SLE) and many other autoimmune dise
162 system is persistently activated in systemic lupus erythematosus (SLE) and many other systemic autoim
163 d susceptibility for development of systemic lupus erythematosus (SLE) and other autoimmune diseases.
165 gen in autoimmune disorders such as systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS).
167 and IL-23 receptor in patients with systemic lupus erythematosus (SLE) as compared with healthy contr
168 Blood monocytes from children with systemic lupus erythematosus (SLE) behave similar to dendritic ce
169 to be the major IFNalpha source in systemic lupus erythematosus (SLE) but their phenotype and functi
175 The role of innate immunity in systemic lupus erythematosus (SLE) has been a rapidly expanding a
177 whether children born to women with systemic lupus erythematosus (SLE) have an increased risk of cong
179 s have demonstrated that women with systemic lupus erythematosus (SLE) have fewer live births and mor
180 th the autoimmune rheumatic disease systemic lupus erythematosus (SLE) have multiple defects in lymph
209 ion-based studies have been done on systemic lupus erythematosus (SLE) mortality trends in the United
213 12.31 was replicated in a cohort of systemic lupus erythematosus (SLE) patients (N = 47) and controls
214 skin-derived endothelial cells from systemic lupus erythematosus (SLE) patients expressed CD95L and t
216 ity landscape of naive B cells from Systemic Lupus Erythematosus (SLE) patients undergoing disease fl
217 ARID3a(+) B cells in nearly half of systemic lupus erythematosus (SLE) patients, and total numbers of
218 ng levels of leptin are elevated in systemic lupus erythematosus (SLE) patients, but it is not clear
221 ve been found to be associated with systemic lupus erythematosus (SLE) susceptibility by a recent gen
222 rotein NADPH oxidase (NADPHO), with systemic lupus erythematosus (SLE) susceptibility in individuals
223 come of 39 variants associated with Systemic Lupus Erythematosus (SLE) through the integration of GWA
224 from large cohorts of patients with systemic lupus erythematosus (SLE) with and without LN and other
225 of inflammatory diseases including systemic lupus erythematosus (SLE), Aicardi-Goutieres syndrome (A
226 in MRL/lpr mice, which are prone to systemic lupus erythematosus (SLE), and inhibited the antiviral i
227 ncy (CVID), Evans syndrome (ES), or systemic lupus erythematosus (SLE), and most achieved a CR (N = 8
228 mplicated in the autoimmune disease systemic lupus erythematosus (SLE), but little is known about the
229 (MHC) locus is well established in systemic lupus erythematosus (SLE), but the causal functional var
230 sis in autoimmune diseases, such as systemic lupus erythematosus (SLE), but the natural history of au
232 nesis of autoimmunity, most notably systemic lupus erythematosus (SLE), diabetes mellitus, and dermat
235 ene ETS1, have been associated with systemic lupus erythematosus (SLE), or lupus, in independent coho
236 eral autoimmune diseases, including systemic lupus erythematosus (SLE), Sjogren's syndrome, inflammat
238 a genome-wide association study of systemic lupus erythematosus (SLE), we observed a single risk hap
240 nked to autoimmune diseases such as systemic lupus erythematosus (SLE), where nucleic acid-containing
241 choroidal changes in patients with systemic lupus erythematosus (SLE), with or without glomeruloneph
243 lls (LysM(Cre)Bim(fl/fl)) develop a systemic lupus erythematosus (SLE)-like disease that mirrors aged
244 We transferred bone marrow from systemic lupus erythematosus (SLE)-prone Sle123 mice into normal,
281 We previously identified IgAN and systemic lupus erythematosus (SLE)/lupus nephritis (LN) shared ma
282 ts are associated with the risk for systemic lupus erythematosus (SLE); however, it is unclear how Ox
283 in the inflammation associated with systemic lupus erythematosus (SLE); however, it remains unclear w
285 esence of autoreactive IgE in human systemic lupus erythematosus subjects was also associated with in
286 esis of autoimmune diseases such as systemic lupus erythematosus, thyroiditis, and rheumatic autoimmu
287 stigating NMDA receptor function in systemic lupus erythematosus, traumatic brain injury, and Parkins
290 ients with rheumatoid arthritis and systemic lupus erythematosus were demethylated compared to health
291 d model of autoimmunity, similar to systemic lupus erythematosus, where both cell types are critical
292 of macrophages in diseases such as systemic lupus erythematosus, where impaired phagocytosis of apop
293 y; however, 1 participant developed systemic lupus erythematosus while on study and was excluded from
294 tions in the brain of patients with systemic lupus erythematosus with and without a history of centra
295 corpus callosum of 13 patients with systemic lupus erythematosus with past NPSLE, 16 patients with sy
297 ons were made between patients with systemic lupus erythematosus with/without past NPSLE and healthy
298 f the most severe manifestations of systemic lupus erythematosus, with considerable morbidity and mor
299 with autoimmune diseases, including systemic lupus erythematosus, with risk correlating with reduced
300 s with past NPSLE, 16 patients with systemic lupus erythematosus without past NPSLE, and 19 healthy c
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。